India News | Human Clinical Trials of Indigenously Developed COVID-19 Vaccine Candidates Move to Phase 2: ICMR
Get latest articles and stories on India at LatestLY. The Phase 1 human clinical trials of two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been completed and the trials have moved to Phase 2, ICMR Director General Balram Bhargava said on Tuesday.
New Delhi, Aug 4 (PTI) The Phase 1 human clinical trials of two COVID-19 vaccine candidates developed indigenously by Bharat Biotech in collaboration with ICMR and Zydus Cadila Ltd have been completed and the trials have moved to Phase 2, ICMR Director General Balram Bhargava said on Tuesday.
Addressing a press briefing, he said once a safe and effective vaccine is developed, the focus should be on prioritisation and its fair distribution, roll-out and cold chain logistics, stockpiling and training of people who would be administering the vaccine.
There are about 141 candidates that are being studied worldover and 26 are in different phases of clinical trials, he said.
"At the present moment, there are three vaccines which are in different phases of clinical testing in India. The first one is the inactivated virus vaccine developed by Bharat Biotech which has completed its Phase 1 study in 11 sites and has started its Phase 2 study. Phase 1 and 2 are safety and very early efficacy studies.
Also Read | Sushant Singh Rajput Suicide Case: Two PILs Filed in Supreme Court for CBI Probe Into Actor's Death.
"Similarly Zydus Cadila's DNA vaccine has also completed Phase 1 studies in 11 sites and started its Phase 2 trials which is also progressing. Recombinant Oxford vaccine to be manufactured by Serum Institute of India, Pune was given approval yesterday for Phase 2 and 3 clinical trials which would start within a week at 17 sites," Bhargava said at the briefing.
Underlining the urgency for the need of a vaccine, the ICMR official said though the pandemic is progressing rapidly, developing a vaccine takes time "not only from the science aspect, but also from the social, cultural and regulatory aspects".
He, however, emphasised that till a safe and effective vaccine becomes available, sustained behavioural change, physical distancing, wearing masks and proper hand hygiene, is probably the best vaccine available at the moment, and even these measures have to be continued absolutely.
PTI PLB UZM SRY 08042207 NNNN, entertaining the the world with dazzling performances.
Moments ahead of the final, Suurbier and his teammates were still joking and making light of the momentous occasion. They led West Germany 1-0 after a minute, but then it all fell apart as the methodological Germans came back to win 2-1.
Suurbier stuck with the national team for four more years, and he came even closer to winning the World Cup in 1978. The Dutch hit the post in the final minutes of regulation time, when a goal would have given them the title. In the end, they lost to host Argentina 3-1, and Suurbier's international career was over.
He later joined Cruyff at the Los Angeles Aztecs in 1979, but his career was sliding. He stayed in the United States for more than three decades, working various coaching jobs and even as a bartender.
As reliable as he was on the field, Suurbier was known for being a happy-go-lucky character off it. He is remembered as much for his pranks about disappearing socks, and worse, as about the trophies he won. (AP)
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)